Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance and metabolite profile of lefamulin in healthy males
NCT03131141Phase 1Completed
- Sponsor
- Nabriva Therapeutics plc
- Start
- Jan 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of lefamulin in bacterial infection (2 cohorts), sponsored by Nabriva Therapeutics plc. Primary endpoints: Amount of radioactivity eliminated in urine, Amount of radioactivity eliminated in feces and 1 more. Started Jan 2017; status: completed.
02
Drugs
lefamulin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03131141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03131141.